What Insiders Bought Last Week: MNKD, LMCA, TISI, WRB, SNTS:

MannKind Corp. (NASDAQ:MNKD): This development stage biopharmaceutical company saw great insider interest. The company CEO and Chairman Alfred E Mann bought 40 million shares at the average purchase price of $2.59. The entire transaction was worth $103.6 million.

MannKind is currently trading at $2.21, up 1.38 percent from its previous close of $2.18. It has traded in the range of $1.57 and $3.48 in the past 52 weeks. However, the stock is trading below its 20 days moving average price of $2.22 and 50 days moving average price of $2.23. Mannkind is currently involved in developing Afrezza, an insulin therapy for treating adults with Type 1 and Type 2 diabetes. The company is based out of California. Mannkind is trading at beta of 0.54 and it reported its latest EPS at -$1.02.

http://www.advfn.com/newspaper/ed-liston/14261/what-insiders-bought-last-week-mnkd-lmca-tisi-wrb-snts